BCCIP Protein, Human (sf9, His-GST)

BCCIP proteins contribute to interphase microtubule organization and anchoring as well as spindle pole organization and stability during mitosis. BCCIP protein may induce cell cycle arrest by enhancing CDK2 inhibition and participate in DNA damage repair through homologous recombination with BRCA2. BCCIP Protein, Human (sf9, His-GST) is the recombinant human-derived BCCIP protein, expressed by Sf9 insect cells , with N-His, N-GST labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: Sf9 insect cells
  • Storage:
    Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

BCCIP proteins contribute to interphase microtubule organization and anchoring as well as spindle pole organization and stability during mitosis. BCCIP protein may induce cell cycle arrest by enhancing CDK2 inhibition and participate in DNA damage repair through homologous recombination with BRCA2. BCCIP Protein, Human (sf9, His-GST) is the recombinant human-derived BCCIP protein, expressed by Sf9 insect cells , with N-His, N-GST labeled tag.

Background

BCCIP, a multifaceted protein, plays crucial roles during interphase and mitosis. In interphase, it is essential for microtubule organizing and anchoring activities, while during mitosis, it contributes significantly to spindle pole organization and stabilization. Notably, isoform 2/alpha emerges as particularly vital in regulating microtubule anchoring, stability, spindle architecture, and orientation, compared to isoform 1/beta. Beyond its structural functions, BCCIP may exert control over the cell cycle by enhancing CDKN1A-mediated inhibition of CDK2 activity, potentially promoting cell cycle arrest. Furthermore, BCCIP may play a role in DNA damage repair through homologous recombination, likely in conjunction with BRCA2, while its involvement in non-homologous end joining (NHEJ) remains unclear. BCCIP engages in diverse interactions, forming complexes with BRCA2, CDKN1A, MTDH/LYRIC, DCTN1/p150-glued, ACTR1A/ARP1, and tubulin subunits. Isoforms 1 and 2 exhibit distinct interaction profiles, with both associating with alpha-, beta-, and gamma-tubulins. Additionally, BCCIP interacts with TENT5C, although this interaction does not impact TENT5C poly(A) polymerase function.

Technical Parameters

  • Species Human
  • Source Sf9 insect cells
  • Tag N-His;N-GST
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • His-GST
    • BCCIP (M1-V314)
      Accession # Q9P287-1
    • C-term
  • Protein Length

    Full Length of Isoform-1

  • Synonyms

    BCCIP; TOK1; BRCA2 And CDKN1A Interacting Protein; BRCA2 And Cip1/P21 Interacting Protein; BRCA2 And CDKN1A-Interacting Protein; Cdk Inhibitor P21 Binding Protein; BCCIPalpha; TOK-1alpha; TOK-1; BCCIPbeta; P21- And CDK-Associated Protein 1; TOK-1beta; Pro

  • AA Sequence

    MASRSKRRAVESGVPQPPDPPVQRDEEEEKEVENEDEDDDDSDKEKDEEDEVIDEEVNIEFEAYSLSDNDYDGIKKLLQQLFLKAPVNTAELTDLLIQQNHIGSVIKQTDVSEDSNDDMDEDEVFGFISLLNLTERKGTQCVEQIQELVLRFCEKNCEKSMVEQLDKFLNDTTKPVGLLLSERFINVPPQIALPMYQQLQKELAGAHRTNKPCGKCYFYLLISKTFVEAGKNNSKKKPSNKKKAALMFANAEEEFFYEKAILKFNYSVQEESDTCLGGKWSFDDVPMTPLRTVMLIPGDKMNEIMDKLKEYLSV

  • Predicted Molecular Mass

    64 kDa

  • Molecular Weight

    Approximately 65 kDa, based on SDS-PAGE under reducing conditions.

  • Glycosylation

    Yes

  • Purity

    ≥ 85%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Solution

Endotoxin Level

<1 EU/μg, determined by LAL method.

Storage & Stability

Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.

Shipping

Shipping with dry ice.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00